Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Geller Biopharm

BioCentury | Jun 23, 2014
Financial News

Parnell Pharmaceuticals completes IPO

BioCentury | Jun 20, 2014
Financial News

Aussie vet co Parnell raises $50M in IPO

BioCentury | Jun 16, 2014
Financial News

Parnell Pharmaceuticals amends IPO

BioCentury | May 26, 2014
Financial News

Parnell Pharmaceuticals proposes IPO

BioCentury | Feb 10, 2014
Financial News

Agenus completes follow-on

BioCentury | Jan 13, 2014
Company News

Cancer Prevention Pharmaceuticals, Zeria deal

BioCentury | Oct 29, 2012
Company News

Igan Biosciences, Shire deal

BioCentury | Oct 1, 2012
Company News

Galaxy, Roche deal

Items per page:
1 - 10 of 14